These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 7511288)

  • 21. Cell proliferation of transitional cell bladder cancer determined by PCNA/cyclin immunostaining. A histopathological description.
    Lipponen PK; Eskelinen MJ
    Anticancer Res; 1992; 12(2):577-83. PubMed ID: 1349799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ki-67 fraction, p53 alteration and numerical chromosome aberrations (chromosomes 7 and 17) in formalin fixed bladder tumors].
    Moch H; Sauter G; Gudat F; Waldman F; Mihatsch MJ
    Verh Dtsch Ges Pathol; 1993; 77():226-30. PubMed ID: 7511286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
    Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
    Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications.
    Popov Z; Gil-Diez-De-Medina S; Ravery V; Hoznek A; Bastuji-Garin S; Lefrere-Belda MA; Abbou CC; Chopin DK
    Urol Oncol; 2004; 22(2):93-101. PubMed ID: 15082004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.
    Cattoretti G; Becker MH; Key G; Duchrow M; Schlüter C; Galle J; Gerdes J
    J Pathol; 1992 Dec; 168(4):357-63. PubMed ID: 1484317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bivariate analysis DNA/cytokeratin 7 and flow cytometric measurement of MIB-1 in superficial transitional carcinoma of the bladder (TCC). Methodological aspects and prognostic implications.
    Leonardi E; Cristofori A; Reich A; Dalla Palma P
    Eur J Histochem; 1997; 41 Suppl 2():133-4. PubMed ID: 9859817
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prognostic study of cell proliferative markers ki67, PCNA and p53 oncoprotein in bladder tumors].
    Ben Rejeb A; Mahjoub A; Berraies N; Tissaoui K
    Ann Urol (Paris); 2000 Aug; 34(4):240-8. PubMed ID: 10994143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New quantitative method for determining p53 protein in bladder carcinomas].
    Moreno Sierra J; Maestro de las Casas ML; Ortega Heredia MD; Chicharro Almarza J; Blanco Jiménez E; Silmi Moyano A; Resel Estévez L
    Arch Esp Urol; 1997 May; 50(4):347-53. PubMed ID: 9313043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inverted transitional-cell papilloma: the expression of the Ki-67 nuclear antigen as a prognostic factor].
    Valero Puerta JA; Redondo Martínez E; Jieménez González C; Gómez Medina ML; Martínez de la Riva SI
    Arch Esp Urol; 1995 Nov; 48(9):887-92. PubMed ID: 8554393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors in bladder carcinoma: histologic parameters and expression of a cell cycle-related nuclear antigen (Ki-67).
    Mulder AH; Van Hootegem JC; Sylvester R; ten Kate FJ; Kurth KH; Ooms EC; Van der Kwast TH
    J Pathol; 1992 Jan; 166(1):37-43. PubMed ID: 1538273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Growth fractions of bladder cancer determined by proliferating cell nuclear antigen immunostaining].
    Kuroda H; Yasunaga Y; Takatera H; Fujioka H; Ohnishi A; Tsujimoto M
    Hinyokika Kiyo; 1994 May; 40(5):379-82. PubMed ID: 7912881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of the transcriptional activity of p53 improves the prediction of recurrence in superficial transitional cell carcinoma of the bladder.
    Dekairelle AF; Tombal B; Cosyns JP; Gala JL
    Clin Cancer Res; 2005 Jul; 11(13):4724-32. PubMed ID: 16000567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The proliferating nuclear fraction as a prognostic factor in superficial bladder carcinomas].
    Belloso L; Zugasti A; Urkia M; Arozena F; Blasco-Olaetxea E
    Arch Esp Urol; 1997 Oct; 50(8):831-6. PubMed ID: 9463280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prognostic value of the immunohistochemical expression of: Ki67, p53, PCNA and Bcl2 in the superficial tumors of the bladder].
    Rammeh-Rommani S; Zermani R; Sfaxi M; Chabchoub A; Zouari B; Ayed M; Ben Jilani-Baltagi S
    Tunis Med; 2007 Jun; 85(6):509-12. PubMed ID: 17644907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. c-erbB-2 gene product-like expression in urothelial carcinomas of the human bladder. Its value as a prognostic indicator in superficial tumors.
    Serio G
    Pathologica; 1991; 83(1086):413-20. PubMed ID: 1686491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PCNA and p53 in urinary bladder cancer: correlation with histological findings and prognosis.
    Inagaki T; Ebisuno S; Uekado Y; Hirano A; Hiroi A; Shinka T; Ohkawa T
    Int J Urol; 1997 Mar; 4(2):172-7. PubMed ID: 9179692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical study of the proliferating ability and malignant potential of transitional cell carcinoma in the human urinary bladder.
    Yoshikawa H; Ikeuchi T; Kai Y
    Int J Urol; 1996 Jan; 3(1 Suppl):S32-4. PubMed ID: 24304017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 and c-jun expression in urinary bladder transitional cell carcinoma: correlation with proliferating cell nuclear antigen (PCNA) histological grade and clinical stage.
    Skopelitou A; Hadjiyannakis M; Dimopoulos D; Kamina S; Krikoni O; Alexopoulou V; Rigas C; Agnantis NJ
    Eur Urol; 1997; 31(4):464-71. PubMed ID: 9187909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical detection of p53 protein, c-erbB-2 protein, epidermal growth factor receptor protein and proliferating cell nuclear antigen in gastric carcinoma.
    Jang WI; Yang WI; Lee CI; Kim HS; Song KS; Cho MY; Park JK; Shim YH
    J Korean Med Sci; 1993 Aug; 8(4):293-304. PubMed ID: 7911025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA flow cytometry and 67Ki proliferating index as prognostic factors of early recurrence and progression in G1-G2/Ta-T1 and G3/Ta-T1 transitional cell carcinoma of the bladder.
    Tizzani A; Casetta G; Gontero P; Giammò A; Ghabin H; Demurtas S; Pacchioni D
    Minerva Urol Nefrol; 1997 Sep; 49(3):141-3. PubMed ID: 9396221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.